The number of adults eligible for GLP-1 drugs may vary by additional requirements employer plans set In setting their coverage requirements, employers will weigh the cost of these drugs against the clinical benefits and demands from their workers and may impose additional eligibility conditions for prescription drug coverage
But for people who currently use medications like Wegovy and Ozempic for weight loss, you may face one of the following issues that have become common across the U.S
Researchers examined reports submitted between the first quarter of 2022 and the third quarter of 2023, a period when GLP-1 prescriptions surged
Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function
Demand for GLP-1 Receptor Agonists in China Based on data released by the Chinese government, 141 million Chinese suffer from diabetes , with the figure expected to increase to 174.4 million in 2045
References: Novo Nordisk A/S: Wegovy pill approved in the US as first oral GLP-1 for weight management - ( Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity - ( Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1Based Weight Loss - ( Source-Medindia
/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788238.jpeg)
